| Literature DB >> 28746816 |
Dagmar Jarkovska1,2, Monika Bludovska1,3, Eliska Mistrova1,2, Vera Krizkova4, Dana Kotyzova3, Tereza Kubikova1,4, Jana Slavikova1, Sumeyye Nur Erek2, Aleksandar Djordjevic2, Magdalena Chottova Dvorakova1,2.
Abstract
Liver cirrhosis is associated with impairment of cardiovascular function including alterations of the heart innervation, humoral and nervous dysregulation, changes in systemic circulation and electrophysiological abnormalities. Choline acetyltransferase (ChAT), enzyme forming acetylcholine, tyrosine hydroxylase (TH), and dopamine-β-hydroxylase (DBH), enzymes participating in noradrenaline synthesis, are responsible for the production of classical neurotransmitters, and atrial natriuretic peptide (ANP) is produced by cardiomyocytes. The aim of this study was to evaluate the influence of experimentally induced hepatic dysfunction on the expression of proANP, ChAT, TH, and DBH in the heart. Hepatic dysfunction was induced by application of thioacetamide (TAA) or by ligation of bile duct. Biochemical parameters of hepatic injury and levels of peroxidation in the liver and heart were measured. Liver enzymes measured in the plasma were significantly elevated. Cardiac level of peroxidation was increased in operated but not TAA group animals. In the left atrium of operated rats, the expression of TH and DBH was lower, while expression of ChAT remained unchanged. In TAA group, no significant differences in the expression of the genes compared to controls were observed. Liver injury induced by ligation leads to an imbalance in the intracardiac innervation, which might impair nervous control of the heart.Entities:
Keywords: bile duct ligation; cardiomyopathie cirrhotique; catecholamines; catécholamines; cirrhotic cardiomyopathy; cœur; heart; intracardiac nervous system; ligature du conduit cholédoque; lipid peroxidation; peroxydation lipidique; système nerveux intracardiaque; thioacetamide; thioacétamide
Mesh:
Substances:
Year: 2017 PMID: 28746816 DOI: 10.1139/cjpp-2017-0060
Source DB: PubMed Journal: Can J Physiol Pharmacol ISSN: 0008-4212 Impact factor: 2.273